Gujarat Themis Biosyn's Q2 FY25 financial results show negative trend, 'Hold' call by MarketsMOJO
Gujarat Themis Biosyn, a smallcap pharmaceutical company, recently announced its financial results for the quarter ending September 2024. According to the report, the company’s financial performance has been negative, with a score of -14 compared to -4 in the previous quarter.
The company’s Profit Before Tax (PBT) has fallen by 20.1% to Rs 13.87 crore, compared to the average PBT of the previous four quarters which was Rs 17.37 crore. This indicates a very negative trend in the near term. Similarly, the Profit After Tax (PAT) has also decreased by 22.7% to Rs 10.57 crore, compared to the average PAT of the previous four quarters which was Rs 13.67 crore.
The company’s Net Sales have also seen a decline of 12.6% to Rs 34.72 crore, compared to the average Net Sales of the previous four quarters which was Rs 39.74 crore. This is the lowest net sales in the last five quarters, indicating a negative trend in the near term. The Operating Profit (PBDIT) has also decreased to its lowest at Rs 15.40 crore in the last five quarters.
The company’s Earnings per Share (EPS) have also declined to its lowest at Rs 0.97 in the last five quarters, indicating a declining profitability and lower earnings for shareholders. Based on these financial results, MarketsMOJO has given a ‘Hold’ call for Guj. Themis Bio. stock.
It is important to note that these financial results are based on the company’s performance in the quarter ending September 2024 and do not reflect any future potential or investor interest. As a smallcap pharmaceutical company, Gujarat Themis Biosyn will continue to face challenges in the highly competitive pharmaceutical industry. Investors are advised to carefully consider these financial results before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
{{text.big_txt}}
{{text .small_txt}}
{{dashverdictresult.dashboard.stock_details.short_name}}
SEND BY EMAIL
Register now to see if the stock’s characteristics match your investment style
Subscribe now to see if the stock's characteristics match your investment style
{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
Create your portfolio and know how much should this stock be in your portfolio
Subscribe now to know how much you should hold in this stock
We have found 2 better stocks that you can consider
{{dashverdictresult.dashboard.return_text}}
Investors Returns (3 years) –
| Period | 6M | 1Y | 2Y | 3Y |
| {{ keyd.val }} | ||||
| {{ keyd.val }} |
Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}
Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}
Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}
Stock Info:
BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}
Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)
Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}
52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}
Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
